Smart Money · Holder IQ
Above median holder quality (percentile 84 this quarter). Tracked high-scoring holders are adding shares.
Reading stored signals…
Healthcare • Biotechnology
No reporting owner has a RED or GREEN connection distinguishable from zero in this publication.
A connection is distinguishable from zero here only when its RED or GREEN published interval has a lower bound above zero. A person with an admitted finding is always listed first, even with a zero score. Connections are then ordered by the larger of RED and GREEN. A zero tied with other owners is not given a percentile.
RED measures graph connections to people with admitted adjudications; GREEN measures connections to repeat value creators and stewards of qualifying compounders and long-term shareholder-return leaders. Net is GREEN minus RED on a −1 to 1 scale, not a probability or expected return. Connections alone do not establish conduct. These measures are separate from insider trading performance and Company Quality Grade.
The publication is uncalibrated. Its intervals are published bands, not a claim of calibrated confidence or a tested forecast.
Admitted findings are published guilty pleas, convictions and litigated SEC judgments or orders. Settlements and open cases are not findings. A positive net does not erase an admitted finding. Absence of a finding is not a clearance or a complete regulatory-history search.
Reporting owners who filed from after Oct 9, 2025 through Oct 9, 2026: a 12-month window ending at the publication date. This can include former officers and directors; it is not a verified roster of today's employees.
Link an account to see your stake, watchlist and past holdings. use the cited filings to check the reported role and evidence alongside your investment thesis. A connection alone does not tell you to increase or reduce a holding.
Medians across all 12 scored reporting owners at this company as of Oct 9, 2026: RED 0, GREEN 0, net 0. Highest RED: 0.000001; highest GREEN: 0.
Robert E. Bancroft · SEC CIK 0002066370
Read the Form 4 filed Feb 19, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: b024bafe9142183b08c57b27ccaf92c41ad55a3038a67b72222c2edcf9fc4f51
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
John Bencich · SEC CIK 0001477056
Read the Form 4 filed Apr 3, 2026Published intervals: RED 0 to 0.020001; GREEN 0 to 0.02; net -0.040001 to 0.039999.
Score identity: ca2a51db6809adb58b15af259274de429d7d9d48a9e0894180c6970e30fb7e97
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Eric G. Carter · SEC CIK 0001387660
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 232663c3229a830e5743b941b943503b172ee709dec450251a9994bcc890524c
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Jost Fischer · SEC CIK 0001366841
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 4392138cec63cdd464ba7a1d03294ca4732ef6fa17b05b86e9f365db931d8fb3
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Marc Forth · SEC CIK 0001816988
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 380a9084779a35748dae6e05eb42f9aafe7f8699bdbbca537ff5faf02249b5ae
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Chad Oh · SEC CIK 0001882166
Read the Form 4 filed Mar 11, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: a39bb4d4d8cabe55b6e95ed287b3005dd7e907a15a9ad4b7ac7c04d2b4bde03a
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Robert J. Palmisano · SEC CIK 0001138646
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.020001; GREEN 0 to 0.02; net -0.040001 to 0.039999.
Score identity: 260ede6d964cb0c33fd0374e9f465f67bccdb11009199af90b4c9f35e033b939
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Jennifer Sy · SEC CIK 0002023998
Read the Form 4 filed Mar 5, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 6b4b01aee5ad3979bd7c9d122079088f9aa4c379faa8e2d4b7b7a6c475cd789a
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Shelley B. Thunen · SEC CIK 0001297491
Read the Form 4 filed Jun 22, 2026Published intervals: RED 0 to 0.020001; GREEN 0 to 0.02; net -0.040001 to 0.039999.
Score identity: 1841a1621bf22daa9e2654196a1a8769e3a5d2604615d29a0821dbd21a3aea86
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Alexander Blair Wilson · SEC CIK 0001979602
Read the Form 4 filed Mar 5, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: a5318cc3c1e704a6c6ddae43a2c776533e8d4086cbc0d6635c82288b9d18cfe9
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Daewoong Co., Ltd · SEC CIK 0001985493
Read the Form 3 filed Jan 29, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 4b8d08dfbbba91e65ceed85f4655b9c2057110dc2e04f3b9bfe011bd0c417c4c
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Timothy P. Lynch · SEC CIK 0001270925
Read the Form 4 filed Aug 21, 2026Published intervals: RED 0 to 0.020001; GREEN 0 to 0.02; net -0.040001 to 0.039999.
Score identity: c03fe0c4242fa8554a50bfacc4b4daf9c97bdaaaf46e39bd400fbe285e4ffde7
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Quarter ended Sep 30, 2026. Source: Stored analyst estimates.
| Observed / analysts | EPS | Revenue |
|---|---|---|
| 4 analysts | -0.0825 | — |
| 4 analysts | -0.0825 | — |
| 4 analysts | -0.0825 | — |
| 4 analysts | -0.0825 | — |
| 3 analysts | -0.0667 | — |
Dates identify stored observations, not earnings announcements. Gaps do not mean estimates were unchanged. The analyst group and vendor earnings basis may change.
Link an account to see your stake, watchlist and past holdings. Compare changes in earnings expectations with your investment case. These are analyst estimates, not reported results or a prediction of your return.
Trailing twelve-month statements · as of Nov 12, 2026
End-of-day close from stored market data, not a live quote.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine.
It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Company profile stored Oct 27, 2026.
The last 8 fiscal quarters from the latest stored normalized financial statements. These may include restatements. Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Jun 30, 2026 | — | — | — | -$5.9M | -$1.2M |
| Mar 2026filed Mar 31, 2026 | — | — | — | -$5.9M | -$11.8M |
| Dec 2025filed Dec 31, 2025 | — | — | — | -$5.5M | -$37.1M |
| Sep 2025filed Sep 30, 2025 | — | — | — | -$2.5M | -$4.5M |
| Jun 2025filed Jun 30, 2025 | — | — | — | -$4.3M | -$6.6M |
| Mar 2025filed Mar 31, 2025 | — | — | — | -$462.0K | $9.1M |
| Dec 2024filed Dec 31, 2024 | — | — | — | -$2.3M | $2.1M |
| Sep 2024filed Sep 30, 2024 | — | — | — | -$4.0M | -$6.2M |
What resources sit beside the obligations? These are balances at each fiscal quarter end, not cash earned during the quarter. Amounts are in USD, the reporting currency.
Vendor filing date:
Vendor filing date:
Vendor filing date:
Vendor filing date:
Link an account to see your stake, watchlist and past holdings. Compare cash and debt across dates when reviewing its reliance on financing. Current assets can include receivables and inventory; current liabilities include bills as well as borrowings. They are not all spendable cash or all debt. These figures alone do not establish the ability to repay.
Source: the latest stored normalized balance sheets, matched to the same security and fiscal end as these income periods. They may include restatements and are not an originally-filed or knowledge-time history. No net debt, coverage ratio or replacement balance is calculated. Read the SEC guide to financial statements for the distinction between balances and cash flows.
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Dec 31, 2025 | — | — | — | -$12.8M | -$39.2M |
| Dec 2024filed Dec 31, 2024 | — | — | — | $73.0M | $42.0M |
| Dec 2023filed Dec 31, 2023 | — | — | — | -$348.1M | -$384.6M |
| Dec 2022filed Dec 31, 2022 | — | — | — | -$48.4M | -$52.6M |
| Dec 2021filed Dec 31, 2021 | — | — | — | -$65.8M | -$55.6M |
| Dec 2020filed Dec 31, 2020 | $2.5M | -25.0% | 100.0% | -$16.4M | -$32.9M |
Does profit turn into cash? Compare AEON’s accounting profit with operating cash flow and capital spending. Amounts are in USD.
Fiscal year ending
Fiscal year ending
Fiscal year ending
Fiscal year ending
Fiscal year ending
Fiscal year ending
Link an account to see your stake, watchlist and past holdings. Compare cash generation and investment needs with your thesis. Working capital and non-cash charges can separate profit from cash. Capital spending can reduce free cash flow while earnings rise. For a long or short position, that gap alone does not predict a price move.
Source: Annual financial statements, latest stored vendor-normalized figures. These may include restatements and may differ from the filer’s own XBRL. A filing date is not the knowledge date of this version of the values.
Free cash flow is the vendor’s reported figure, shown only when it agrees with operating cash flow less capital spending recorded as a positive outflow. It is not cash guaranteed for dividends or buybacks, and it does not subtract every financing obligation. Missing or sign-incompatible inputs are not filled in. An unlabelled currency is used only for a confirmed domestic USD filer. These are annual statements, not forecasts or an originally-filed history.
Where did AEON’s financing cash go? Compare cash paid as dividends with net share and debt transactions across fiscal years. Amounts are in USD, the reporting currency. These are company-wide totals, not per-share payouts.
Vendor filing date:
Vendor filing date:
Vendor filing date:
Vendor filing date:
Vendor filing date:
Vendor filing date:
Link an account to see your stake, watchlist and past holdings. Compare these uses of cash with operating cash generation and the debt on the balance sheet. A negative net share movement means purchases exceeded issuance; it does not give gross buybacks. A dividend or share purchase can be financed with borrowing, and none of these flows guarantees a future payment or price return.
Source: Annual cash-flow statements, latest stored vendor-normalized values for the same security and fiscal year. These can include restatements; a filing date is not the knowledge date of this version.
Dividends are positive cash paid out. For net share transactions, net borrowing and total financing, positive means cash in and negative means cash out. Net share transactions combine issuance and purchases; they are not gross repurchases, a change in shares outstanding, or stock compensation. Total financing includes other flows and is not the sum of just these three lines. Zero means a reported zero. No FX conversion, shareholder-return total or forecast is inferred.
Reported short positions, stored float percentages and adjusted prices over the same period.
Shares short
Share of float
Adjusted close · USD
Settlement Oct 30, 2026
2,661,529 shares short
-589,171 shares (-18.1%) vs Oct 15, 2026
11.1% of the stored float. Published Nov 10, 2026.
Settlement Oct 15, 2026
3,250,700 shares short
+1,079,072 shares (+49.7%) vs Sep 30, 2026
13.5% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
2,171,628 shares short
-776,323 shares (-26.3%) vs Sep 15, 2026
9% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
2,947,951 shares short
+1,136,780 shares (+62.8%) vs Aug 31, 2026
29.7% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
1,811,171 shares short
+684,473 shares (+60.8%) vs Aug 14, 2026
Published Sep 10, 2026.
Settlement Aug 14, 2026
1,126,698 shares short
+249,731 shares (+28.5%) vs Jul 31, 2026
Published Aug 25, 2026.
Settlement Jul 31, 2026
876,967 shares short
-235,822 shares (-21.2%) vs Jul 15, 2026
Published Aug 11, 2026.
Settlement Jul 15, 2026
1,112,789 shares short
+952,520 shares (+594.3%) vs Jun 30, 2026
Published Jul 24, 2026.
Settlement Jun 30, 2026
160,269 shares short
-17,626 shares (-9.9%) vs Jun 15, 2026
Published Jul 10, 2026.
Settlement Jun 15, 2026
177,895 shares short
-41,325 shares (-18.9%) vs May 29, 2026
Published Jun 25, 2026.
Settlement May 29, 2026
219,220 shares short
-12,668 shares (-5.5%) vs May 15, 2026
Published Jun 9, 2026.
Settlement May 15, 2026
231,888 shares short
+75,492 shares (+48.3%) vs Apr 30, 2026
Published May 27, 2026.
Settlement Apr 30, 2026
156,396 shares short
+53,166 shares (+51.5%) vs Apr 15, 2026
Published May 11, 2026.
Settlement Apr 15, 2026
103,230 shares short
-41,580 shares (-28.7%) vs Mar 31, 2026
Published Apr 24, 2026.
Settlement Mar 31, 2026
144,810 shares short
-133,389 shares (-47.9%) vs Mar 13, 2026
Published Apr 10, 2026.
Settlement Mar 13, 2026
278,199 shares short
+68,584 shares (+32.7%) vs Feb 27, 2026
Published Mar 24, 2026.
Settlement Feb 27, 2026
209,615 shares short
-12,356 shares (-5.6%) vs Feb 13, 2026
Published Mar 10, 2026.
Settlement Feb 13, 2026
221,971 shares short
-31,795 shares (-12.5%) vs Jan 30, 2026
Published Feb 25, 2026.
Settlement Jan 30, 2026
253,766 shares short
+73,280 shares (+40.6%) vs Jan 15, 2026
Published Feb 10, 2026.
Settlement Jan 15, 2026
180,486 shares short
+136,256 shares (+308.1%) vs Dec 31, 2025
Published Jan 27, 2026.
Settlement Dec 31, 2025
44,230 shares short
-18,618 shares (-29.6%) vs Dec 15, 2025
Published Jan 12, 2026.
Settlement Dec 15, 2025
62,848 shares short
+6,729 shares (+12%) vs Nov 28, 2025
Published Dec 24, 2025.
Settlement Nov 28, 2025
56,119 shares short
-48,079 shares (-46.1%) vs Nov 14, 2025
Published Dec 9, 2025.
Settlement Nov 14, 2025
104,198 shares short
+66,861 shares (+179.1%) vs Oct 31, 2025
Published Nov 25, 2025.
Settlement Oct 31, 2025
37,337 shares short
-189,087 shares (-83.5%) vs Oct 15, 2025
Published Nov 11, 2025.
Settlement Oct 15, 2025
226,424 shares short
+112,185 shares (+98.2%) vs Sep 30, 2025
Published Oct 24, 2025.
Settlement Sep 30, 2025
114,239 shares short
+9,488 shares (+9.1%) vs Sep 15, 2025
Published Oct 9, 2025.
Settlement Sep 15, 2025
104,751 shares short
-51,131 shares (-32.8%) vs Aug 29, 2025
Published Sep 24, 2025.
Settlement Aug 29, 2025
155,882 shares short
-98,073 shares (-38.6%) vs Aug 15, 2025
Published Sep 10, 2025.
Settlement Aug 15, 2025
253,955 shares short
-74,345 shares (-22.6%) vs Jul 31, 2025
Published Aug 26, 2025.
Settlement Jul 31, 2025
328,300 shares short
-33,008 shares (-9.1%) vs Jul 15, 2025
Published Aug 11, 2025.
Settlement Jul 15, 2025
361,308 shares short
-140,718 shares (-28%) vs Jun 30, 2025
Published Jul 24, 2025.
Settlement Jun 30, 2025
502,026 shares short
+68,747 shares (+15.9%) vs Jun 13, 2025
Published Jul 10, 2025.
Settlement Jun 13, 2025
433,279 shares short
-744,916 shares (-63.2%) vs May 30, 2025
Published Jun 25, 2025.
Settlement May 30, 2025
1,178,195 shares short
+1,001,583 shares (+567.1%) vs May 15, 2025
Published Jun 10, 2025.
Settlement May 15, 2025
176,612 shares short
+107,671 shares (+156.2%) vs Apr 30, 2025
Published May 27, 2025.
Settlement Apr 30, 2025
68,941 shares short
-302,141 shares (-81.4%) vs Apr 15, 2025
Published May 9, 2025.
Settlement Apr 15, 2025
371,082 shares short
+160,905 shares (+76.6%) vs Mar 31, 2025
Published Apr 25, 2025.
Settlement Mar 31, 2025
210,177 shares short
+36,183 shares (+20.8%) vs Mar 14, 2025
Published Apr 9, 2025.
Settlement Mar 14, 2025
173,994 shares short
-219,239 shares (-55.8%) vs Feb 28, 2025
Published Mar 25, 2025.
Settlement Feb 28, 2025
393,233 shares short
Published Mar 11, 2025.
Settlement Feb 14, 2025
2,665,565 shares short
-311,839 shares (-10.5%) vs Jan 31, 2025
Published Feb 26, 2025.
Settlement Jan 31, 2025
2,977,404 shares short
+1,784,963 shares (+149.7%) vs Jan 15, 2025
Published Feb 11, 2025.
Settlement Jan 15, 2025
1,192,441 shares short
+1,131,349 shares (+1,851.9%) vs Dec 31, 2024
Published Jan 27, 2025.
Settlement Dec 31, 2024
61,092 shares short
-132,442 shares (-68.4%) vs Dec 13, 2024
Published Jan 10, 2025.
Settlement Dec 13, 2024
193,534 shares short
+110,097 shares (+132%) vs Nov 29, 2024
Published Dec 24, 2024.
Settlement Nov 29, 2024
83,437 shares short
-80,820 shares (-49.2%) vs Nov 15, 2024
Published Dec 10, 2024.
Settlement Nov 15, 2024
164,257 shares short
+26,813 shares (+19.5%) vs Oct 31, 2024
Published Nov 26, 2024.
Settlement Oct 31, 2024
137,444 shares short
-15,669 shares (-10.2%) vs Oct 15, 2024
Published Nov 11, 2024.
Settlement Oct 15, 2024
153,113 shares short
+19,428 shares (+14.5%) vs Sep 30, 2024
Published Oct 24, 2024.
Settlement Sep 30, 2024
133,685 shares short
+65,032 shares (+94.7%) vs Sep 13, 2024
Published Oct 9, 2024.
Settlement Sep 13, 2024
68,653 shares short
-58,046 shares (-45.8%) vs Aug 30, 2024
Published Sep 24, 2024.
Settlement Aug 30, 2024
126,699 shares short
-4,823 shares (-3.7%) vs Aug 15, 2024
Published Sep 11, 2024.
Settlement Aug 15, 2024
131,522 shares short
-491,312 shares (-78.9%) vs Jul 31, 2024
Published Aug 26, 2024.
Settlement Jul 31, 2024
622,834 shares short
+472,203 shares (+313.5%) vs Jul 15, 2024
Published Aug 9, 2024.
Settlement Jul 15, 2024
150,631 shares short
+4,739 shares (+3.2%) vs Jun 28, 2024
Published Jul 24, 2024.
Settlement Jun 28, 2024
145,892 shares short
-866 shares (-0.6%) vs Jun 14, 2024
Published Jul 10, 2024.
Settlement Jun 14, 2024
146,758 shares short
-33,606 shares (-18.6%) vs May 31, 2024
Published Jun 26, 2024.
Settlement May 31, 2024
180,364 shares short
+56,875 shares (+46.1%) vs May 15, 2024
Published Jun 11, 2024.
Settlement May 15, 2024
123,489 shares short
-68,440 shares (-35.7%) vs Apr 30, 2024
Published May 24, 2024.
Settlement Apr 30, 2024
191,929 shares short
-240,911 shares (-55.7%) vs Apr 15, 2024
Published May 9, 2024.
Settlement Apr 15, 2024
432,840 shares short
+73,253 shares (+20.4%) vs Mar 28, 2024
Published Apr 24, 2024.
Settlement Mar 28, 2024
359,587 shares short
+213,627 shares (+146.4%) vs Mar 15, 2024
Published Apr 9, 2024.
Settlement Mar 15, 2024
145,960 shares short
+65,941 shares (+82.4%) vs Feb 29, 2024
Published Mar 26, 2024.
Settlement Feb 29, 2024
80,019 shares short
+15,107 shares (+23.3%) vs Feb 15, 2024
Published Mar 11, 2024.
Settlement Feb 15, 2024
64,912 shares short
+3,973 shares (+6.5%) vs Jan 31, 2024
Published Feb 27, 2024.
Settlement Jan 31, 2024
60,939 shares short
+10,104 shares (+19.9%) vs Jan 12, 2024
Published Feb 9, 2024.
Settlement Jan 12, 2024
50,835 shares short
+20,130 shares (+65.6%) vs Dec 29, 2023
Published Jan 24, 2024.
Settlement Dec 29, 2023
30,705 shares short
-1,239 shares (-3.9%) vs Dec 15, 2023
Published Jan 10, 2024.
Settlement Dec 15, 2023
31,944 shares short
-8,492 shares (-21%) vs Nov 30, 2023
Published Dec 26, 2023.
Settlement Nov 30, 2023
40,436 shares short
-14,172 shares (-26%) vs Nov 15, 2023
Published Dec 11, 2023.
Settlement Nov 15, 2023
54,608 shares short
-8,421 shares (-13.4%) vs Oct 31, 2023
Published Nov 24, 2023.
Settlement Oct 31, 2023
63,029 shares short
-594 shares (-0.9%) vs Oct 13, 2023
Published Nov 9, 2023.
Settlement Oct 13, 2023
63,623 shares short
-10,242 shares (-13.9%) vs Sep 29, 2023
Published Oct 24, 2023.
Settlement Sep 29, 2023
73,865 shares short
+69,483 shares (+1,585.6%) vs Sep 15, 2023
Published Oct 10, 2023.
Settlement Sep 15, 2023
4,382 shares short
-1,684 shares (-27.8%) vs Aug 31, 2023
Published Sep 26, 2023.
Settlement Aug 31, 2023
6,066 shares short
-6,173 shares (-50.4%) vs Aug 15, 2023
Published Sep 11, 2023.
Settlement Aug 15, 2023
12,239 shares short
-768 shares (-5.9%) vs Jul 31, 2023
Published Aug 24, 2023.
Settlement Jul 31, 2023
13,007 shares short
Published Aug 9, 2023.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records. Adjusted prices exclude a reused ticker’s earlier issuer. FINRA data and reporting dates · How to read short interest
Through Nov 13, 2026
Recorded amounts and dates, not confirmation of cash received.
| Ex-date | Event | Recorded detail |
|---|---|---|
| Feb 26, 2025 | Reverse split | 1 for 72Each 72 pre-split shares become 1 post-split share. |
Cash bars retain the event's recorded currency and share basis. The yield line divides recorded cash in the preceding 365 days, adjusted for intervening splits, by a verified raw close in the same currency. Special dividends are included. Future ex-dates are excluded from yield. A split changes share count, not investment value. For long shares, past entitlement depends on when you held them; short shares can create a dividend payment obligation.
Source: recorded cash-dividend and split events.
Link an account to see your stake, watchlist and past holdings.
We’ll show you if AEON is in your portfolio and how much it contributes.
Sign in3 smart-money holders: institutions with a high Holder IQ
Sentiment: neutral
Last trade: buy 84 days ago
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 4
22 filers reported a long position in AEON for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
99.9%
of the 12.8M shares 13-F filers reported
Moves vs Q1 2026
4 added1 trimmed
1 new · 4 unchanged
Net shares held
+356.5%
across the 9 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Dauntless Investment Group, LLC | $9M · 12.5M shares | 12.5M | +394.1% |
| 2 | Geode Capital Management, LLC | $68.6K · 95.3K shares | 95.3K | +9.5% |
| 3 | Vanguard Capital Management LLC | $65.1K · 90.5K shares | 90.5K | Unchanged |
| 4 | Blue Owl Capital Holdings LP | $30.5K · 42.4K shares | 42.4K | Unchanged |
| 5 | Formidable Asset Management, LLC | $19.7K · 20K shares | 20K | Unchanged |
| 6 | StoneX Group Inc. | $14.9K · 19K shares | 19K | New |
| 7 | Vanguard Fiduciary Trust Co | $9.9K · 13.7K shares | 13.7K | -6.7% |
| 8 | LPL Financial LLC | $8.3K · 11.5K shares | 11.5K | Unchanged |
| 9 | Citigroup Inc | $5.3K · 7.3K shares | 7.3K | +885.8% |
| 10 | UBS Group AG | $3.6K · 5.1K shares | 5.1K | +21% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inHolders of more than 5% of AEON file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Nov 10, 2026 | Daewoong Co Ltd13D · activist · amended | 30.6% |
| Aug 21, 2026 | Lynch Timothy P13G · passive | 13% |
| Jul 21, 2026 | Stonepine Capital Management, LLC13G · passive | 9.9% |
How much of AEON’s move accompanied the market and its measured style leanings, and how much was left? The residual is unexplained by this fitted model. It does not establish a cause, skill or future alpha.
Return split unavailable. A complete, reconciled model for every market session in this window is unavailable. Missing dates are not filled.
Link an account with dated transactions to see what share of your own holding’s move since its purchase-date close was unexplained, with long and short positions distinguished. Your private holdings never enter this public chart.
Daily percentage returns, not window contributions. Source: the same dated warehouse rows and model v1.2.0; observed 2026-11-13T15:35:34.103Z. Absent sessions are never interpolated; missing or failed inputs stay unavailable.
| Date | Stock | Market | Styles | Residual |
|---|---|---|---|---|
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable |
Each day uses that day’s fitted market intercept and style exposures multiplied by that day’s published factor returns. Their sum plus the independently stored residual must reconcile to the stock return. Window effects are weighted by stock wealth at each day’s start and added; the stock return compounds. Every expected US market session must be present and pass source, identity, model and numerical checks. This retrospective fit is an explanation of measured returns, not evidence of causation or an investable forecast. The window ends at the latest published model session, which can lag the market; today’s unfinished session is excluded.
Reading dated filing evidence…
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.
Read the balances behind the trades: SEC Forms 3, 4 and 5 state a reporting owner’s position, not just an amount bought or sold. These are dated filing observations, not current holdings or a trading signal.
Class A Common Stock, $0.0001 par value per share · Indirect · Non-derivative shares · By Daewoong Pharmaceutical Co., Ltd.
23,184,523 shares in the latest stored filing
Filed · report period Oct 30, 2026 · Form 4. Source: SEC filing 0001213900-26-117865. Quantities are reported units, not currency or market value.
SEC identifiers: reporting-owner CIK 0001985493 · issuer CIK 0001837607
Source: stored SEC Forms 3/4/5 ownership records filed Nov 10, 2026; read Nov 13, 2026, 3:35 PM UTC. Exact quantities and each accession are below. A single dot is one observation, not a trend.
· 23,184,523 shares in stored record · Indirect
Report period Oct 30, 2026 · Form 4 · balance after the filing’s transactions. SEC 0001213900-26-117865
Link an account to see your stake, watchlist and past holdings. A reported balance adds context to a sale or purchase: an insider may still report a substantial position. This view does not calculate a percentage sold or a combined insider total. Different classes, indirect vehicles, derivatives and joint filers may overlap; changes can also reflect awards, gifts, exercises, splits or corrections. Neither a balance nor a change predicts your return.
Available filings through Nov 13, 2026; read Nov 13, 2026, 3:35 PM UTC. Latest 240 stored rows, up to 24 distinct reporting-owner positions. The bounded sample is truncated; older or additional positions may exist. 9 rows are outside the displayed position bound or have incompatible identities and are withheld. No holdings or account data about the reader enters this public evidence.
1Y price return -82.6%
Prices adjusted for splits; dividends excluded.
Nov 12, 2025–Nov 12, 2026. Returns are rebased to the first displayed observation. Prices use the latest stored close's share basis, linked backward through stored price returns. Marks use their recorded calendar dates, including non-trading days; their lanes do not imply a price or that an event caused a move.
Insiders: green purchases, red sales. Other lanes: 13F reporting period ends, stored earnings-calendar dates and flagged filings. Select a mark or open the dated list for its evidence.
Reported evidence, not a forecast
Above median holder quality (percentile 84 this quarter). Tracked high-scoring holders are adding shares.
Activity worth watching. Last 180 days of filings: 1 purchases, 0 sales, 8 other records. Open-market net over the last 90 days: +$243.5K.
Late Form 4 filing